- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT05967195
Prova per aumentare la partecipazione alla FEP
Incentivi finanziari per aumentare la frequenza al trattamento nella cura della psicosi del primo episodio: uno studio pilota non randomizzato e adattivo
Individuals with first-episode psychosis (FEP) are at high-risk for several poor functional and clinical outcomes, including suicide. Coordinated Specialty Care (CSC) is a multidisciplinary, team-based intervention known to improve such outcomes, including suicide risk. However, 30-50% of patients disengage from CSC, thereby limiting its impact. This pilot study will develop and test feasibility of a behavioral change program that uses moderate financial incentives to encourage treatment engagement in 2 CSC programs. A single-arm of 80 patient-participants at these two clinics will be recruited to assess feasibility and acceptability from patient perspectives. Additionally,15 clinicians at these two clinics will be recruited to assess feasibility and acceptability from clinician perspectives, and 50 clinicians from peer clinics not involved in the intervention will be recruited to assess scalability of the intervention. The trial will feature an three-month period for recruitment and baseline data collection and will subsequently feature three intervention periods (3 months each) where modifications to the interventions will be tested (each informed by the feasibility and acceptability findings of the prior period) with the aim of sequentially improving it.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Prima fase 1
Contatti e Sedi
Luoghi di studio
-
-
North Carolina
-
Raleigh, North Carolina, Stati Uniti, 27608
- University of North Carolina at Chapel Hill (ENCOMPASS Program)
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Stati Uniti, 19123
- PEACE Program, Horizon House, Inc.
-
Philadephia, Pennsylvania, Stati Uniti, 19104
- University of Pennsylvania
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- For all participants, age ≥ 18 years old.
- For intervention trial and patient feasibility and acceptability measurement: Patients with first-episode psychosis, enrolled in Coordinated Specialty Care at the Psychosis Education, Assessment, Care and Empowerment (PEACE) clinic and Psychosis Evaluation and Recovery Center (PERC).
- For clinician feasibility and acceptability measurement at intervention sites: Clinicians working at PEACE and PERC where the intervention will be piloted.
- For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: Clinicians in Connection LHS who work at sites other than PEACE and PERC.Participants must sign the informed consent form
Exclusion Criteria:
- For intervention trial and patient feasibility and acceptability measurement: Expectation of leaving coordinated specialty care programing within 6 months (which will exclude all of the PI's patient panel) and/or intellectual disability of sufficient degree that the patient's primary psychiatrist expects to compromise capacity to consent to this research and/or psychosis secondary to another medical condition (which may not share the same motivational features that are otherwise understood about the primary psychiatric conditions with psychosis).
- For clinician feasibility and acceptability measurement at intervention sites: Study investigators who work at these clinics will be excluded from participation in the feasibility and acceptability study component given their role in the trial planning and execution.
- For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: none.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Non randomizzato
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Acceptability of intervention measure (AIM)
Lasso di tempo: Change at 8 months
|
The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. |
Change at 8 months
|
|
Acceptability of intervention measure (AIM)
Lasso di tempo: Change at 6 months
|
The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. |
Change at 6 months
|
|
Acceptability of intervention measure (AIM)
Lasso di tempo: Change at 4 months
|
The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. |
Change at 4 months
|
|
Feasibility of intervention measure (FIM)
Lasso di tempo: Change at 8 months
|
The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. |
Change at 8 months
|
|
Feasibility of intervention measure (FIM)
Lasso di tempo: Change at 6 months
|
The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. |
Change at 6 months
|
|
Feasibility of intervention measure (FIM)
Lasso di tempo: Change at 4 months
|
The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. |
Change at 4 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Implementation Survey Response
Lasso di tempo: Change at 8 months
|
Implementation survey. Results will be used to optimize intervention from implementation perspective. |
Change at 8 months
|
|
Implementation Survey Response
Lasso di tempo: Change at 6 months
|
Implementation survey. Results will be used to optimize intervention from implementation perspective. |
Change at 6 months
|
|
Implementation Survey Response
Lasso di tempo: Change at 4 months
|
Implementation survey. Results will be used to optimize intervention from implementation perspective. |
Change at 4 months
|
|
Motivation Survey Response
Lasso di tempo: Change at 8 months
|
Motivation survey. Results will be used to optimize intervention from motivation perspective. |
Change at 8 months
|
|
Motivation Survey Response
Lasso di tempo: Change at 6 months
|
Motivation survey. Results will be used to optimize intervention from motivation perspective. |
Change at 6 months
|
|
Motivation Survey Response
Lasso di tempo: Change at 4 months
|
Motivation survey. Results will be used to optimize intervention from motivation perspective. |
Change at 4 months
|
|
Ethical Concern Survey Response
Lasso di tempo: Change at 8 months
|
Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. |
Change at 8 months
|
|
Ethical Concern Survey Response
Lasso di tempo: Change at 6 months
|
Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. |
Change at 6 months
|
|
Ethical Concern Survey Response
Lasso di tempo: Change at 4 months
|
Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. |
Change at 4 months
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
attrition
Lasso di tempo: Change at 8 months
|
rate of attrition |
Change at 8 months
|
|
attrition
Lasso di tempo: Change at 6 months
|
rate of attrition |
Change at 6 months
|
|
attrition
Lasso di tempo: Change at 4 months
|
rate of attrition |
Change at 4 months
|
|
psychotic symptomology
Lasso di tempo: Change at 8 months
|
Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. |
Change at 8 months
|
|
psychotic symptomology
Lasso di tempo: Change at 6 months
|
Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. |
Change at 6 months
|
|
psychotic symptomology
Lasso di tempo: Change at 4 months
|
Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. |
Change at 4 months
|
|
psychotic symptomology
Lasso di tempo: Change at 8 months
|
modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. |
Change at 8 months
|
|
psychotic symptomology
Lasso di tempo: Change at 6 months
|
modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. |
Change at 6 months
|
|
psychotic symptomology
Lasso di tempo: Change at 4 months
|
modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. |
Change at 4 months
|
|
depression
Lasso di tempo: Change at 8 months
|
abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) |
Change at 8 months
|
|
depression
Lasso di tempo: Change at 6 months
|
abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) |
Change at 6 months
|
|
depression
Lasso di tempo: Change at 4 months
|
abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) |
Change at 4 months
|
|
quality of life
Lasso di tempo: Change at 8 months
|
4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) |
Change at 8 months
|
|
quality of life
Lasso di tempo: Change at 6 months
|
4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) |
Change at 6 months
|
|
quality of life
Lasso di tempo: Change at 4 months
|
4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) |
Change at 4 months
|
|
recovery
Lasso di tempo: Change at 8 months
|
5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) |
Change at 8 months
|
|
recovery
Lasso di tempo: Change at 6 months
|
5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) |
Change at 6 months
|
|
recovery
Lasso di tempo: Change at 4 months
|
5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) |
Change at 4 months
|
|
treatment motivation (intrinsic versus extrinsic)
Lasso di tempo: Change at 8 months
|
Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. |
Change at 8 months
|
|
treatment motivation (intrinsic versus extrinsic)
Lasso di tempo: Change at 6 months
|
Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. |
Change at 6 months
|
|
treatment motivation (intrinsic versus extrinsic)
Lasso di tempo: Change at 4 months
|
Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. |
Change at 4 months
|
|
Perceived coercion
Lasso di tempo: Change at 8 months
|
Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. |
Change at 8 months
|
|
Perceived coercion
Lasso di tempo: Change at 6 months
|
Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. |
Change at 6 months
|
|
Perceived coercion
Lasso di tempo: Change at 4 months
|
Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. |
Change at 4 months
|
|
attendance rate
Lasso di tempo: Change over 8 months
|
number of appointments attended in a given period divided by number of appointments scheduled |
Change over 8 months
|
|
attendance rate
Lasso di tempo: Change at 6 months
|
number of appointments attended in a given period divided by number of appointments scheduled |
Change at 6 months
|
|
attendance rate
Lasso di tempo: Change at 4 months
|
number of appointments attended in a given period divided by number of appointments scheduled |
Change at 4 months
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- 2023-03
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .